Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study

BACKGROUND/AIMS: Pirfenidone slows the progression of idiopathic pulmonary fibrosis (IPF). We investigated its efficacy and safety in terms of dose and disease severity in real-world patients with IPF. METHODS: This multicenter retrospective cohort study investigated 338 patients treated with pirfen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hyeontaek, Lee, Jung-Kyu, Choi, Sun Mi, Lee, Yeon Joo, Cho, Young-Jae, Yoon, Ho Il, Lee, Jae Ho, Lee, Choon-Taek, Kim, Young Whan, Park, Jong Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925945/
https://www.ncbi.nlm.nih.gov/pubmed/34293852
http://dx.doi.org/10.3904/kjim.2020.559